|
OMIM |
Link |
Information gain |
01 |
|
GRA
|
[NCBI]
|
0.00610047
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.00266538
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
0.0024437
|
|
|
hypokalemia, familial
|
[NCBI]
|
0.000938013
|
|
|
CYP11B2
|
[NCBI]
|
0.000364603
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
0.000342881
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
0.00016175
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
0.000146427
|
|
|
liddle syndrome
|
[NCBI]
|
0.00013611
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
0.000126099
|
|
|
NPPA
|
[NCBI]
|
0.000100586
|
|
|
CYP11B1
|
[NCBI]
|
9.64867e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
5.60904e-05
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
5.35226e-05
|
|
|
PTH
|
[NCBI]
|
5.12422e-05
|
|
|
PHA2
|
[NCBI]
|
4.7658e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
4.7658e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
4.7658e-05
|
|
|
SCNN1B
|
[NCBI]
|
4.32798e-05
|
|
|
SLC12A3
|
[NCBI]
|
4.26611e-05
|
|
|
AGTR1
|
[NCBI]
|
4.00443e-05
|
|
|
CF
|
[NCBI]
|
3.67089e-05
|
|
|
CYP17A1
|
[NCBI]
|
3.5382e-05
|
|
|
CALCRL
|
[NCBI]
|
3.26639e-05
|
|
|
hypertension, essential
|
[NCBI]
|
2.90029e-05
|
|
|
STAR
|
[NCBI]
|
2.69779e-05
|
|
|
ADM
|
[NCBI]
|
2.05981e-05
|
|
|
VHL
|
[NCBI]
|
1.88802e-05
|
|
|
CRH
|
[NCBI]
|
1.45847e-05
|
|
|
POMC
|
[NCBI]
|
1.39765e-05
|
|
|
AVP
|
[NCBI]
|
1.17025e-05
|
|
|
SPP1
|
[NCBI]
|
8.50606e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
5.34985e-06
|
|
|
VEGF
|
[NCBI]
|
4.85861e-06
|
|
|
G6PD
|
[NCBI]
|
4.83742e-06
|
|
|
CFTR
|
[NCBI]
|
4.16322e-06
|
|
|
TH
|
[NCBI]
|
3.22832e-06
|
|
|
NPY
|
[NCBI]
|
2.11814e-06
|
|
|
APC
|
[NCBI]
|
2.64156e-07
|
|
|
PRL
|
[NCBI]
|
1.46271e-07
|
|